Bebo HealthXPAR:MLBBO 47 ROA % is 0.22% as of Dec. 2025, which is 82% below its 10-year median of 1.20. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,129 Retail - Cyclical companies, Bebo Health ranks worse than 69.44% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Bebo Health's annualizedNet Income for the quarter that ended in Dec. 2025 was €0.04 Mil.
Bebo Health's average Total Assets over the quarter that ended in Dec. 2025 was €19.29 Mil. Therefore, Bebo Health's annualized ROA % for the quarter that ended in Dec. 2025 was 0.22%.
The historical rank and industry rank for Bebo Health's ROA % or its related term are showing as below:
XPAR:MLBBO'
s ROA % Range Over the Past 10 Years
Min: 0.12 Med: 1.2 Max: 33.97
Current: 0.22
During the past 7 years, Bebo Health's highest ROA % was 33.97%. The lowest was 0.12%. And the median was 1.20%.
XPAR:MLBBO's ROA % is ranked worse than 69.44% of 1129
companies
in the Retail - Cyclical industry
Industry Median: 2.72
vs XPAR:MLBBO: 0.22
Bebo Health (XPAR:MLBBO) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Dec. 2025) net income data. The Revenue data used here is one times the annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Bebo Health ROA % Related Terms
Bebo Health ROA % Historical Data
* Premium members only.
The historical data trend for Bebo Health's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Retail subindustry, Bebo Health's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health ROA % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's ROA % distribution charts can be found below:
* The bar in red indicates where Bebo Health's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Bebo Health (XPAR:MLBBO) has a ROA % of 0.22% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Bebo Health and its competitors. This is 82% below median its historical median of 1.20. Over the past decade, Bebo Health's ROA % has ranged from 0.12 to 33.97. According to the industry distribution chart, Bebo Health ranks #784 out of 1129 companies in the Retail - Cyclical industry, placing it in the top 69.4%.
Is Bebo Health's ROA % too high?
Bebo Health's current ROA % of 0.22% is 82% below median its 10-year median of 1.20. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 33.97. The Retail - Cyclical industry median ROA % is 2.72. Bebo Health's value of 0.22% is 91.9% below this industry median. Based on the distribution chart, Bebo Health ranks #784 out of 1129 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's ROA % compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #784 out of 1129 companies for ROA %. This places Bebo Health in the lower half of its industry. The industry median ROA % is 2.72. Bebo Health's value of 0.22% is 91.9% below this benchmark. Historically, Bebo Health's own ROA % has ranged from 0.12 to 33.97 over the past decade. While the company's 10-year median is 1.20 vs. the industry median of 2.72, Bebo Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Retail - Cyclical company?
The median ROA % among Retail - Cyclical companies is 2.72, based on 1,129 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current ROA % of 0.22% is 91.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median ROA % is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current ROA % is 0.22%, which is 82% below median its own 10-year median of 1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.23 — trading 660% above its estimated fair value. The current ROA % is 0.22%, which is 82% below median its 10-year median of 1.20 and 91.9% below the Retail - Cyclical industry median of 2.72. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current ROA % is 0.22% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.23 is trading 660% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
ROA %: 0.22% (82% below median its 10-year median of 1.20)
GF Value™: €0.03 vs. price of €0.23 (660% above fair value)
Industry Position: 91.9% below the Retail - Cyclical median (#784 of 1129)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 